The Latest Breaking News from Multiple Sclerosis

"Our results are a window of opportunity for new research strategies of demyelinating diseases such as MS."

MMJ companies are building a center of marijuana excellence in Rhode Island and has filed for FDA sanctioned clinical trials in multiple sclerosis and Huntington's disease. MMJ was awarded the much coveted orphan drug designation from the FDA for its planned Huntington's disease trials, and has also received a D

Leuchie House ambassador Alan Kyle tells of his shock at being diagnosed with Multiple Sclerosis and how his 76-year-old mum is his lifeline

Dr Irene Molina-González (34) will take on the Full Tilt Ultra during the Blair Castle Trail Weekender, near Pitlochry

Zoe Sadler only ate cheese and onion crisp sandwiches for 23 years and turned to a hypnotist after being diagnosed with multiple sclerosis. She was cured after two two-hour hypnotherapy sessions

Late last week, Atara Biotherapeutics Inc (NASDAQ:ATRA) announced that Bayer AG (OTC:BAYRY) intends to terminate the exclusive worldwide licensing agreement for Atara's mesothelin-targeted allogeneic and autologous CAR-T assets, ATA3271 and ATA2271. The enrollment was paused in the Phase 1 trial of ATA2271 for mesothelioma after a patient death. The move followed a strategic review and asset-level prioritization.…

Former high-flying West Coast Eagles player Ashley Sampi posts on social media announcing his multiple sclerosis diagnosis and committing to raise funds to fight the disease.

Biogen Inc (NASDAQ:BIIB) posted Q1 sales of 2.53 billion, beating the consensus of $2.49 billion, down 6% Y/Y. Multiple sclerosis (MS) revenue, including royalties on sales of Ocrevus, of $1.79 billion decreased by 3%.  Spinraza's revenue of $441 million decreased 9% at actual currency and 6% at constant currency.  Aduhelm's revenue was…

Laura Ingram admits she cannot afford to have a lazy day – in case her condition worsens.